Akin Gump has hired Dechert’s Gorav Jindal, a specialist in the pharmaceutical industry and a former antitrust attorney at the Federal Trade Commission, at a time when antitrust breaches are on US government enforcement agencies’ radar.
Antitrust litigator Gorav Jindal has arrived at Akin Gump Strauss Hauer & Feld’s litigation practice as a partner in Washington, DC, from Philadelphia-headquartered Dechert, where he was a partner in the antitrust practice for three years, having previously served at that firm as an associate for nine years and an attorney for one year.
Jindal began his legal career at the US Federal Trade Commission (FTC), where he spent almost two years as an antitrust attorney in the Bureau of Competition, investigating merger and acquisitions transactions in the publishing, computer hardware and chemical industries.
In his private practice, he assists corporates under investigation by the FTC and the US Department of Justice (DoJ), and also deals with evaluation and allocation of antitrust risk in deal documents, as well as issues arising from theHart-Scott-Rodino Antitrust Improvements Act, which places an obligation on companies to make a detailed filing with the FTC and the DoJ before completing certain mergers.
Full Content: CDR News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh